Bank of New York Mellon Corp lowered its holdings in Smith & Nephew plc (NYSE:SNN) by 4.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 58,063 shares of the medical equipment provider’s stock after selling 2,914 shares during the quarter. Bank of New York Mellon Corp’s holdings in Smith & Nephew were worth $2,033,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Eagle Asset Management Inc. grew its position in Smith & Nephew by 41.9% in the 4th quarter. Eagle Asset Management Inc. now owns 13,040 shares of the medical equipment provider’s stock valued at $456,000 after purchasing an additional 3,849 shares during the period. First Allied Advisory Services Inc. grew its position in Smith & Nephew by 29.8% in the 4th quarter. First Allied Advisory Services Inc. now owns 8,866 shares of the medical equipment provider’s stock valued at $307,000 after purchasing an additional 2,036 shares during the period. First Trust Advisors LP grew its position in Smith & Nephew by 34.2% in the 4th quarter. First Trust Advisors LP now owns 12,790 shares of the medical equipment provider’s stock valued at $448,000 after purchasing an additional 3,260 shares during the period. Sei Investments Co. grew its position in Smith & Nephew by 1.8% in the 4th quarter. Sei Investments Co. now owns 131,946 shares of the medical equipment provider’s stock valued at $4,619,000 after purchasing an additional 2,371 shares during the period. Finally, Nuance Investments LLC grew its position in Smith & Nephew by 31.0% in the 4th quarter. Nuance Investments LLC now owns 2,043,781 shares of the medical equipment provider’s stock valued at $71,553,000 after purchasing an additional 484,016 shares during the period. 6.89% of the stock is owned by institutional investors and hedge funds.

How to Become a New Pot Stock Millionaire

Shares of NYSE:SNN opened at $38.16 on Tuesday. The company has a current ratio of 2.03, a quick ratio of 1.06 and a debt-to-equity ratio of 0.31. Smith & Nephew plc has a 1-year low of $31.77 and a 1-year high of $40.43. The firm has a market cap of $16,724.57, a price-to-earnings ratio of 20.08, a P/E/G ratio of 2.21 and a beta of 0.62.

The business also recently disclosed a None dividend, which will be paid on Wednesday, May 9th. Shareholders of record on Friday, April 6th will be paid a dividend of $0.444 per share. The ex-dividend date is Thursday, April 5th. Smith & Nephew’s dividend payout ratio (DPR) is presently 35.79%.

SNN has been the topic of several recent analyst reports. ValuEngine cut Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Friday, February 9th. Canaccord Genuity restated a “buy” rating on shares of Smith & Nephew in a research note on Thursday, February 8th. JPMorgan Chase upgraded Smith & Nephew from a “neutral” rating to an “overweight” rating in a research note on Thursday, January 25th. Zacks Investment Research upgraded Smith & Nephew from a “hold” rating to a “buy” rating and set a $42.00 price objective on the stock in a research note on Wednesday, April 11th. Finally, HSBC upgraded Smith & Nephew from a “hold” rating to a “buy” rating in a research note on Monday, March 26th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $43.50.

ILLEGAL ACTIVITY NOTICE: “Bank of New York Mellon Corp Trims Position in Smith & Nephew plc (SNN)” was published by Daily Political and is owned by of Daily Political. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.dailypolitical.com/2018/04/17/bank-of-new-york-mellon-corp-trims-position-in-smith-nephew-plc-snn.html.

Smith & Nephew Profile

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew plc (NYSE:SNN).

Institutional Ownership by Quarter for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.